share_log

China OKs Trial for AIM Vaccine Unit's Hand, Foot, and Mouth Disease Vaccine Candidate; Shares Rise 3%

中国はAIMワクチン株手足口病候補ワクチン試験を承認した;株価は3%上昇

MT Newswires ·  2022/10/30 23:56

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする